Pharmaceuticals by short interest
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
TG Therapeutics leads the 61 pharmaceuticals ranked by short interest, at 19.0%, ahead of Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%). Figures as of the 30 Oct 2026 settlement date, from FINRA's short interest report, with shares outstanding from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- TG Therapeutics19.0%
- Median
- 5.47%
- Combined market value
- SEK 51.71T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Short interest % ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | TG TherapeuticsTGTX · Health Care | 19.0% | SEK 97.3B | SEK 643.72 | 0.89% up | 107% up | ||
| 2 | Rhythm PharmaceuticalsRYTM · Health Care | 16.8% | SEK 82.2B | SEK 1,186.31 | 0.01% down | 13% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | 16.5% | SEK 49.3B | SEK 876.20 | 0.99% down | 113% up | ||
| 4 | Protagonist TherapeuticsPTGX · Health Care | 15.7% | SEK 82.7B | SEK 1,266.59 | 0.14% down | 46% up | ||
| 5 | Praxis Precision MedicinesPRAX · Health Care | 15.1% | SEK 86.8B | SEK 3,104.20 | 0.01% up | 61% up | ||
| 6 | CytokineticsCYTK · Health Care | 12.9% | SEK 73.2B | SEK 525.45 | 0.01% down | 20% down | ||
| 7 | Ionis PharmaceuticalsIONS · Health Care | 12.7% | SEK 45.9B | SEK 275.31 | 0.37% up | 64% down | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | 12.3% | SEK 60B | SEK 2,998.54 | 0.31% up | 43% up | ||
| 9 | Spyre TherapeuticsSYRE · Health Care | 12.2% | SEK 91B | SEK 958.56 | 0.43% up | 286% up | ||
| 10 | AlkermesALKS · Health Care | 11.7% | SEK 79.1B | SEK 470.86 | 1.83% up | 58% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | 11.6% | SEK 45.4B | SEK 414.34 | 3.13% down | 88% up | ||
| 12 | BridgeBio PharmaBBIO · Health Care | 10.7% | SEK 153.1B | SEK 785.75 | 0.56% up | 17% up | ||
| 13 | ErascaERAS · Health Care | 10.6% | SEK 46.9B | SEK 133.69 | 5.40% down | 403% up | ||
| 14 | Cogent BiosciencesCOGT · Health Care | 10.0% | SEK 50B | SEK 287.27 | 1.38% up | 20% down | ||
| 15 | Mirum PharmaceuticalsMIRM · Health Care | 9.99% | SEK 60.5B | SEK 927.07 | 0.90% down | 31% up | ||
| 16 | Travere TherapeuticsTVTX · Health Care | 9.96% | SEK 48.7B | SEK 507.69 | 2.35% down | 44% up | ||
| 17 | Oruka TherapeuticsORKA · Health Care | 9.53% | SEK 66.5B | SEK 980.90 | 0.09% up | 241% up | ||
| 18 | PTC TherapeuticsPTCT · Health Care | 9.31% | SEK 51.2B | SEK 612.89 | 0.20% down | 20% down | ||
| 19 | Madrigal PharmaceuticalsMDGL · Health Care | 9.20% | SEK 97.7B | SEK 4,206.78 | 2.02% down | 24% down | ||
| 20 | Jazz PharmaceuticalsJAZZ · Health Care | 9.03% | SEK 158.5B | SEK 2,468.87 | 0.81% up | 37% up | ||
| 21 | Corcept TherapeuticsCORT · Health Care | 8.34% | SEK 75.1B | SEK 685.77 | 3.81% down | 8% down | ||
| 22 | Arrowhead PharmaceuticalsARWR · Health Care | 8.19% | SEK 61.9B | SEK 437.75 | 0.08% up | 10% up | ||
| 23 | VeradermicsMANE · Health Care | 8.03% | SEK 53B | SEK 1,256.01 | 1.74% down | 233% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | 7.29% | SEK 117.6B | SEK 607.30 | 2.02% up | 11% up | ||
| 25 | Definium TherapeuticsDFTX · Health Care | 7.02% | SEK 39.8B | SEK 290.37 | 2.86% down | 169% up | ||
| 26 | Elanco Animal HealthELAN · Health Care | 6.59% | SEK 133.6B | SEK 267.28 | 1.62% up | 20% up | ||
| 27 | InsmedINSM · Health Care | 6.42% | SEK 266.1B | SEK 1,213.07 | 2.16% down | 40% down | ||
| 28 | Roivant SciencesROIV · Health Care | 6.28% | SEK 284.7B | SEK 392.88 | 0.25% down | 90% up | ||
| 29 | Axsome TherapeuticsAXSM · Health Care | 6.20% | SEK 70.9B | SEK 1,347.17 | 2.60% down | 7% down | ||
| 30 | Legend BiotechLEGN · Health Care | 6.13% | SEK 31.7B | SEK 163.30 | 0.37% down | 42% down | ||
| 31 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | 5.47% | SEK 76.3B | SEK 971.64 | 0.41% up | 126% up | ||
| 32 | Summit TherapeuticsSMMT · Health Care | 5.28% | SEK 85.8B | SEK 107.24 | 1.22% down | 36% down | ||
| 33 | ABIVAXABVX · Health Care | 4.70% | SEK 74.4B | SEK 850.08 | 1.77% up | 27% down | ||
| 34 | Ascendis PharmaASND · Health Care | 4.57% | SEK 180.2B | SEK 2,747.34 | 0.43% down | 28% up | ||
| 35 | United TherapeuticsUTHR · Health Care | 4.31% | SEK 247B | SEK 5,799.55 | 2.41% down | 23% up | ||
| 36 | ZoetisZTS · Health Care | 4.12% | SEK 345.9B | SEK 851.28 | 0.23% up | 29% down | ||
| 37 | Alnylam PharmaceuticalsALNY · Health Care | 4.08% | SEK 208.5B | SEK 1,557.01 | 2.21% down | 66% down | ||
| 38 | Belite BioBLTE · Health Care | 3.40% | SEK 65.5B | SEK 1,613.78 | 0.57% up | 31% up | ||
| 39 | Amneal PharmaceuticalsAMRX · Health Care | 3.27% | SEK 76B | SEK 218.24 | 1.56% up | 83% up | ||
| 40 | ViatrisVTRS · Health Care | 3.07% | SEK 240.1B | SEK 209.44 | 0.66% up | 96% up | ||
| 41 | Dr. Reddy's LaboratoriesRDY · Health Care | 3.03% | SEK 126.8B | SEK 152.05 | 1.05% up | 5% up | ||
| 42 | Teva Pharmaceutical IndustriesTEVA · Health Care | 2.38% | SEK 501.7B | SEK 429.96 | 0.84% down | 74% up | ||
| 43 | PfizerPFE · Health Care | 2.36% | SEK 1.63T | SEK 286.35 | 1.14% down | 14% up | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | 2.29% | SEK 1.24T | SEK 608.72 | 2.48% down | 34% up | ||
| 45 | Royalty PharmaRPRX · Health Care | 2.27% | SEK 399.8B | SEK 695.31 | 0.50% down | 78% up | ||
| 46 | Regeneron PharmaceuticalsREGN · Health Care | 2.14% | SEK 1.01T | SEK 9,715.66 | 0.30% down | 36% up | ||
| 47 | Vertex PharmaceuticalsVRTX · Health Care | 1.90% | SEK 1.38T | SEK 5,423.87 | 0.21% down | 27% up | ||
| 48 | GenmabGMAB · Health Care | 1.57% | SEK 321.6B | SEK 521.53 | 1.35% down | 70% up | ||
| 49 | BeOne MedicinesONC · Health Care | 1.40% | SEK 468.9B | SEK 4,105.34 | 2.36% down | 17% up | ||
| 50 | Abbott LaboratoriesABT · Health Care | 1.10% | SEK 1.84T | SEK 1,059.95 | 0.51% down | 17% down | ||
| 51 | Merck & CoMRK · Health Care | 1.08% | SEK 3.5T | SEK 1,421.44 | 2.55% down | 51% up | ||
| 52 | AbbVieABBV · Health Care | 0.89% | SEK 5.17T | SEK 2,924.17 | 1.85% down | 26% up | ||
| 53 | GrifolsGRFS · Health Care | 0.88% | SEK 58.9B | SEK 86.58 | 1.39% down | 1% up | ||
| 54 | Novo NordiskNVO · Health Care | 0.87% | SEK 1.77T | SEK 401.83 | 2.96% down | 17% down | ||
| 55 | Eli LillyLLY · Health Care | 0.81% | SEK 12.63T | SEK 14,174.91 | 1.58% down | 35% up | ||
| 56 | GSKGSK · Health Care | 0.81% | SEK 996B | SEK 496.91 | 0.81% down | 6% up | ||
| 57 | Johnson & JohnsonJNJ · Health Care | 0.71% | SEK 6.74T | SEK 2,798.01 | 1.32% down | 38% up | ||
| 58 | SanofiSNY · Health Care | 0.51% | SEK 1.16T | SEK 481.14 | 0.50% down | 4% down | ||
| 59 | NovartisNVS · Health Care | 0.24% | SEK 3T | SEK 1,591.04 | 1.73% down | 25% up | ||
| 60 | AstraZenecaAZN · Health Care | 0.20% | SEK 2.82T | SEK 1,819.56 | 1.88% down | 2% up | ||
| 61 | Takeda PharmaceuticalTAK · Health Care | 0.10% | SEK 694.8B | SEK 217.47 | 1.22% down | 54% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; short interest from FINRA, the owner and source of the data, as of the 30 Oct 2026 settlement date.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Source: FINRA. Short interest is the shares sold short and not yet covered as brokers reported them to FINRA for the 30 Oct 2026 settlement date; FINRA publishes it about seven business days later, so it is not today's figure. It is divided by shares outstanding worked out as the market value over the share price, both from the same quote — not by the float, so the percent reads lower than a percent of float would. For a company with more than one class of shares the market value covers every class, which lowers it further. Sums are converted from US dollars at today's exchange rate (1 USD = 10.1742 SEK).
Questions and answers
Which pharmaceuticals rank first by short interest?
TG Therapeutics (19.0%), Rhythm Pharmaceuticals (16.8%) and Dianthus Therapeutics (16.5%) are the top three of the 61 pharmaceuticals ranked by short interest as of the 30 Oct 2026 settlement date.
How many pharmaceuticals are in this ranking?
61 are ranked by short interest.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by short interest have a combined market value of SEK 51.71T as of the 30 Oct 2026 settlement date.
What does ranking by short interest measure?
Shares sold short and not yet covered, as reported to FINRA for the latest settlement date, as a percent of shares outstanding (market value divided by share price), not of the smaller float.
Learn how this ranking works
All markets guides →- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
Cite this page
Funkfolio, “Pharmaceuticals by short interest”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=short-interest
Underlying data: FINRA short interest (the 30 Oct 2026 settlement date); Yahoo Finance.